Comorbidity and Multimorbidity: Measurement and Interventions Holly M. Holmes, MD, MS Dept of General Internal Medicine.

Slides:



Advertisements
Similar presentations
“ Handle with Care” A GP guide to cancer care for elderly patients.
Advertisements

Charlotte Carlson, MD, MPH Clinical Geriatrics Fellow University of California at San Francisco AAHCM Annual Meeting, May 14, 2014, Orlando, FL ©AAHCM.
99.98% of the time patients are on their own “The diabetes self-management regimen is one of the most challenging of any for chronic illness.” 0.02% of.
Centre Cérébrovasculaire COMORBIDITY ANALYSIS AND 3 MONTHS FUNCTIONAL OUTCOME IN ACUTE ISCHEMIC STROKE: DATA FROM ACUTE STROKE REGISTRY AND ANALYSIS.
CRITICAL READING OF THE LITERATURE RELEVANT POINTS: - End points (including the one used for sample size) - Surrogate end points - Quality of the performed.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Provision of Preventive Services in the Complex Patient AHRQ.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
Specialised Geriatric Services Heather Gilley Sharon Straus.
Looking at Frailty Through a New Lens John Strandmark, M.D. ©AAHCM.
Individualization Strategies for Older Patients with Diabetes Elbert S. Huang, MD MPH FACP University of Chicago.
Introduction to Healthcare and Public Health in the US The Evolution and Reform of Healthcare in the US Lecture b This material (Comp1_Unit9b) was developed.
Blood Cancers in older adults Cancer and Older Adults 19 November 2015 Matthew Foster, MD Assistant Professor of Medicine Leukemia, Lymphoma and Myeloma.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Promoting Patient Involvement in Medication Decisions David H. Hickam, MD, MPH Professor, Dept. of Medicine Oregon Health & Science University Portland,
Treatment Guidelines and Disease State Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
Geriatric Medicine Sensible Practice in Modern Societies Liang-Kung Chen, MD PhD FRCP Aging and Health Research Center, National Yang Ming University,
Benefits of Guideline Standards to Older Americans: a patient perspective IOM Committee on Standards for Developing Trustworthy Clinical Practice Guidelines.
Medicines management in the elderly Trudi McIntosh and Kim Munro School of Pharmacy and Life Sciences RGU.
Developing and Implementing Intervention Studies Using Geriatric Assessment Supriya Gupta Mohile, M.D., M.S. Assistant Professor of Medicine James Wilmot.
Treatment Guidelines and Disease State Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: December 2015.
PRAGMATIC Study Designs: Elderly Cancer Trials
The PRECIS-2 tool: Matching Intent with Methods David Hahn, MD, MS, WREN Director Department of Family Medicine & Community Health University.
Mobility Interventions for Older Cancer Patients: Design Issues Heidi D. Klepin, M.D., M.S. Associate Professor of Medicine Comprehensive Cancer Center.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
An Overview of Geriatric Oncology: From Research to Clinical Practice
Landon Marshall, Pharm. D. , Matt Hill, Pharm. D. , Jim Wilson, Pharm
Patient engagement in Quality of Care Measurement
MULTIMORBIDITY Suggestions for Lecturer -1-hour lecture
DIAGNOSIS No symptoms = no heart failure. DIAGNOSIS No symptoms = no heart failure.
Patient Focused Drug Development An FDA Perspective
Global burden of diseases
Presentation for Healthcare Professionals
Surgical ICU, Heart Institute University of São Paulo
Evidence-based Medicine
Table 1: Patient Demographics
Cindy Hatton President & CEO Susan Levitt V.P. Clinical Services/COO
Quality of Life Assessment
Trends in Use of Pulmonary Rehabilitation Among Older Adults with Chronic Obstructive Pulmonary Disease Anita C. Mercado, Shawn P. Nishi, Wei Zhang, Yong-Fang.
MULTIMORBIDITY Suggestions for Lecturer -1-hour lecture
Medical Care Cost of Medicare/Medicaid Beneficiaries with Vision Loss
Medication Reconciliation in Continuing Care
Measurement Wu Gong, MS, MD
Definition of Cancer Screening
Value of Pharmaceuticals in Managed Care Pharmacy
The Relationship Between Mental and Physical Health
Heart Failure/Late Problems: End of Life Care: Psychology
PHQ2 Screening Negative PHQ2 Screening Positive
Precision Oncology Carolyn M. Hutter, PhD.
Value of Pharmaceuticals in Managed Care Pharmacy
Value of Pharmaceuticals in Managed Care Pharmacy
MULTIMORBIDITY: THE MOST COMMON CHRONIC CONDITION
Multimorbidity: prevention and management
S1316 analysis details Garnet Anderson Katie Arnold
Martha Watson, MS, APRN, GCNS Christie Bowser, RN-BC
2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada Papaioannou A, et al. CMAJ 2010 Oct 12. [Epub ahead of print].
Non-Pharmacological Therapies, Chronic Pain and Opioid Addictions
Interhospital Transfers to MUSC
Jennifer M. Croswell, Barnett S. Kramer  Journal of Hepatology 
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Using EMRs to personalize and prioritize HIV care: Future research directions R. Scott Braithwaite, MD, MS, FACP Chief, Section of Value and Comparative.
Treatment Guidelines and Disease State Management
A PILOT STUDY EXAMINING CRITERIA USED TO SELECT DRUGS FOR HOSPITAL, PROVINCIAL AND NATIONAL FORMULARIES Robertson J, Newby DA, Pillay T, Walkom EJ The.
Lecture 4 Study design and bias in screening and diagnostic tests
Frailty Cara Hanley November 2016.
Frailty and Its Effect on the 4 M’s
Systems Engineering: Complexity and Personalization are Key to Good Geriatric Care Christine Cassel, MD Planning Dean, Kaiser Permanente School of Medicine.
Treatment Guidelines and Disease State Management
Value of Pharmaceuticals in Managed Care Pharmacy
Presentation transcript:

Comorbidity and Multimorbidity: Measurement and Interventions Holly M. Holmes, MD, MS Dept of General Internal Medicine

Gaps: Incorporating Concepts of Comorbidity into GA and Interventions What do we mean when we talk about comorbidity and multimorbidity? What is the intervention for multimorbidity? How does illness burden in multimorbidity impact quality of life and functional outcomes in cancer?

Comorbidity measures – what is the what? Why What When How Commonly used comorbidity indices Index choice based on study characteristics The importance of comorbid conditions In general Particular to cancer Definitions of comorbidity Generic vs. disease-specific Situations in which it may be important to measure comorbidity

Measuring comorbidity in cancer A coexisting medical condition that exists along with an index condition that has implications for an outcome. No gold standard Particular importance in cancer – Confounder or mediator of effect – Outcome of interest – Distinguish from toxicity Sorensen HT. Clin Epi 2013:5 (suppl1):1-2. Ritchie CS. J Oncol Practice 2011;7:371-4.

What to measure: individual comorbidities vs. a summated index Patnaik JL et al. J Natl Cancer Inst Jul 20; 103(14): 1101–1111.

Use your index properly… Developed to be predictive of length of stay, hospital charges, and in- hospital mortality Independent effects of conditions >> do not simplify into an index Elixhauser, Med Care 1998 Jan;36:8-27.

How to measure comorbidity? Depends on the study question, data sources, population. Sarfati, J Clin Epi 2012; 65: Some key considerations when selecting a useful comorbidity scale in patients with cancer.

Comorbidity and Prognosis Howlander, JNCI Monographs, 2014;49:

Impact of Number of Chronic Conditions on Life Expectancy DuGoff EH, et al. Med Care 2014;52:

Koroukian, S. M. et al. J Clin Oncol; 24: Colorectal CancerBreast Cancer Colorectal CancerBreast Cancer Comorbidity ≠ Disability ≠ Geriatric Syndromes

What is Multimorbidity? Koroukian S, et al. J Geriatr Oncol 2011;2:200-8.

More than half of people 65 and older have 3+ chronic conditions Comorbid Disease Comorbid Disease Comorbid Disease Index Disease Multimorbidity Patient Condition Comorbidity Boyd, CM, Fortin M. Public Health Reviews, 2011.

Importance of Multimorbidity Increased risk of: – Death – Institutionalization – Increased utilization of healthcare resources – Decreased quality of life – Higher rates of adverse effects of treatment or interventions Almost all existing “guidelines” have single disease focus Best approaches to decision-making and clinical management of older adults with multimorbidity remain unclear Brendan Smialowski (NY Times) AGS Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc 2012;60:

How do you measure multimorbidity? Tooth L, et al. J Clin Epi 2008;61:151-59

AGS Guiding Principles as an intervention for multimorbidity?  Patient Preferences: Recognize preference-sensitive decisions  Interpreting the Evidence: Embrace uncertainty  Prognosis: Incorporate multimorbidity-adjusted prognosis  Treatment Complexity and Feasibility: Think about complexity and feasibility  Optimizing Therapies and Care Plans: Carefully balance benefits and harms AGS Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc 2012;60:

How does multimorbidity impact cancer treatment and survivorship? Benefits and harms Treatment burden Symptom burden Decision making Ritchie CS et al. J Oncol Practice 2011;7:371-4

Overcoming the gaps in multimorbidity Can we standardize comorbidity/multimorbidity assessment in GA trials? Can we define multimorbid patients with cancer and consider the impact on treatment decision-making, quality of life and survivorship? Can the guiding principles for multimorbidity be operationalized as an intervention in GA trials? What are the optimal designs, outcome measures, and statistical methods for trials in multimorbid patients?